Cochrane Abstracts
Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Treatment Discontinuation With Selective Serotonin Reuptake Inhibitors (SSRIs) Versus Tricyclic Antidepressants (TCAs)." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440009/all/Treatment_discontinuation_with_selective_serotonin_reuptake_inhibitors__SSRIs__versus_tricyclic_antidepressants__TCAs_.
Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440009/all/Treatment_discontinuation_with_selective_serotonin_reuptake_inhibitors__SSRIs__versus_tricyclic_antidepressants__TCAs_. Accessed April 18, 2026.
Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440009/all/Treatment_discontinuation_with_selective_serotonin_reuptake_inhibitors__SSRIs__versus_tricyclic_antidepressants__TCAs_
Treatment Discontinuation With Selective Serotonin Reuptake Inhibitors (SSRIs) Versus Tricyclic Antidepressants (TCAs) [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440009/all/Treatment_discontinuation_with_selective_serotonin_reuptake_inhibitors__SSRIs__versus_tricyclic_antidepressants__TCAs_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)
ID - 440009
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440009/all/Treatment_discontinuation_with_selective_serotonin_reuptake_inhibitors__SSRIs__versus_tricyclic_antidepressants__TCAs_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
